Clostridium difficile: assessing the risks to Australia of an emerging healthcare-related pathogen

Date & time

12.30–1.30pm 27 November 2014

Location

Bob Douglas Lecture Theatre, Building 62 NCEPH (entrance on Eggleston Road)

Speakers

Luis Furuya Kanamori, PhD Candidate, NCEPH-RSPH

Contacts

 Vasoontara Yieng

Luis began his PhD candidature in infectious disease epidemiology at the National Centre for Epidemiology and Population Heath in 2014. He is a medical graduate from the Universidad Peruana Cayetano Heredia (Peru) and last year he completed the MEpi and MPH at the University of Queensland.

Abstract

Clostridium difficile is the most common cause of antibiotic associated diarrhea among hospital inpatients. The incidence and severity of C. difficile infection have increased worldwide in the last two decades and it is largely due to the emergence of hypervirulent C. difficile strains. Of great concern is the identification of hypervirulent C. difficile PCR ribotype 027 infection cases in Australia. It is imperative to understand the epidemiology of C. difficile and assess the risk of outbreaks of severe C. difficile cases in Australia; therefore, the proposed PhD project aims (1) to determine the C. difficile ribotypes associated with hospital and community-acquired C. difficile disease in Brisbane and Perth, and changes in the ribotype profile over three years and (2) to determine the prevalence of C. difficile colonization in  asymptomatic patients of two major Australian tertiary hospitals in Brisbane and Perth and changes in prevalence over three years.

Updated:  23 October 2017/Responsible Officer:  Director/Page Contact:  Webmaster